Blue Trust Inc’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$87.7M Sell
75,762
-1,367
-2% -$1.61M 0.92% 18
2026
Q2
$92.5M Sell
77,129
-972
-1% -$993K 0.97% 18
2026
Q1
$71.8M Sell
78,101
-7,052
-8% -$7.15M 0.82% 23
2025
Q4
$91.5M Sell
85,153
-4,474
-5% -$4.28M 1.03% 20
2025
Q3
$68.4M Sell
89,627
-484
-0.5% -$360K 0.77% 23
2025
Q2
$70.2M Buy
90,111
+39,094
+77% +$30.4M 0.83% 22
2025
Q1
$42.1M Sell
51,017
-2,159
-4% -$1.8M 0.54% 26
2024
Q4
$41.1M Sell
53,176
-5,971
-10% -$4.94M 0.53% 30
2024
Q3
$53.6M Buy
59,147
+6,114
+12% +$5.5M 0.7% 27
2024
Q2
$41.3M Buy
53,033
+3,649
+7% +$2.92M 0.57% 29
2024
Q1
$38.4M Sell
49,384
-6,180
-11% -$4.4M 0.54% 29
2023
Q4
$29.8M Sell
55,564
-3,214
-5% -$1.88M 0.48% 28
2023
Q3
$27.6M Buy
58,778
+511
+0.9% +$263K 0.42% 32
2023
Q2
$20M Sell
58,267
-2,681
-4% -$1.12M 0.32% 35
2023
Q1
$22.3M Sell
60,948
-2,421
-4% -$817K 0.37% 35
2022
Q4
$20.5M Buy
63,369
+1,944
+3% +$689K 0.37% 36
2022
Q3
$19.9M Buy
61,425
+4,858
+9% +$1.54M 0.35% 34
2022
Q2
$16.2M Buy
+56,567
New +$17M 0.25% 38

Other funds holding LLY

Blue Trust Inc's LLY Position: Q3 2026 in Review

Blue Trust Inc reduced its Eli Lilly (LLY) stake by 1.8% in Q3 2026, selling an estimated $1.61M and leaving 75,762 shares worth $87.7M. The position accounts for 0.92% of the portfolio, ranked #18.

Blue Trust Inc first reported a position in LLY in Q2 2022 and has held it in 18 quarters since. The position peaked at $92.5M in Q2 2026. 1,509 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Blue Trust Inc held 75,762 shares of Eli Lilly worth $87.7M as of Q3 2026.
  • Blue Trust Inc sold 1,367 Eli Lilly shares in Q3 2026, an estimated $1.61M.
  • Eli Lilly made up 0.92% of Blue Trust Inc's portfolio in Q3 2026, its #18 holding.
  • Blue Trust Inc first reported a position in Eli Lilly in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust Inc's Eli Lilly position peaked at $92.5M in Q2 2026.
  • 1,509 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Blue Trust Inc's 13F filing for Q3 2026, filed 15 Oct 2026.